The estimated Net Worth of Rudy Howard is at least $664 Tysiąc dollars as of 4 August 2015. Mr. Howard owns over 5,000 units of vTv Therapeutics Inc stock worth over $72,550 and over the last 10 years he sold VTVT stock worth over $0. In addition, he makes $591,379 as Chief Financial Officer i Executive Vice President at vTv Therapeutics Inc.
Rudy has made over 2 trades of the vTv Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VTVT stock worth $75,000 on 4 August 2015.
The largest trade he's ever made was buying 5,000 units of vTv Therapeutics Inc stock on 4 August 2015 worth over $75,000. On average, Rudy trades about 667 units every 0 days since 2014. As of 4 August 2015 he still owns at least 5,000 units of vTv Therapeutics Inc stock.
You can see the complete history of Mr. Howard stock trades at the bottom of the page.
Rudy C. Howard CPA serves as Chief Financial Officer, Executive Vice President of the Company. Mr. Howard served from January 2010 through May of 2015 as Chief Financial Officer of SciQuest, Inc., an international spend management software company. From November 2008 until joining SciQuest, Mr. Howard served as Senior Vice President and Chief Financial Officer of MDS Pharma Services, a pharmaceutical services company. From 2003 until joining MDS Pharma Services, Mr. Howard operated his own financial consulting company, Rudy C. Howard, CPA Consulting, in Wilmington, North Carolina, where his services included advising on merger and acquisition transactions, equity and debt issuances and other general management matters. From 2001 through 2003, Mr. Howard served as Chief Financial Officer for Peopleclick, Inc., an international human capital management software company. From 2000 until joining Peopleclick, Mr. Howard served as Chief Financial Officer for Marketing Services Group, Inc., a marketing and internet technology company. From 1995 until 2000, Mr. Howard served as Chief Financial Officer for PPD, Inc., a clinical research organization. Prior to joining PPD, Mr. Howard was a partner with PricewaterhouseCoopers. Mr. Howard holds a B.A. in Accounting from North Carolina State University, and he is a Certified Public Accountant.
As the Chief Financial Officer i Executive Vice President of vTv Therapeutics Inc, the total compensation of Rudy Howard at vTv Therapeutics Inc is $591,379. There are 1 executives at vTv Therapeutics Inc getting paid more, with Stephen Holcombe having the highest compensation of $832,803.
Rudy Howard is 62, he's been the Chief Financial Officer i Executive Vice President of vTv Therapeutics Inc since 2015. There are 5 older and 2 younger executives at vTv Therapeutics Inc. The oldest executive at vTv Therapeutics Inc is Howard Weiner, 75, who is the Independent Director.
Rudy's mailing address filed with the SEC is C/O ARAVIVE, INC., RIVER OAKS TOWER,, 3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX, 77098.
Over the last 9 years, insiders at vTv Therapeutics Inc have traded over $100,050 worth of vTv Therapeutics Inc stock and bought 38,545,137 units worth $116,272,024 . The most active insiders traders include Ronald O Perelman, Srinivas Akkaraju oraz Bros. Advisors Lp667, L.P.B.... On average, vTv Therapeutics Inc executives and independent directors trade stock every 33 days with the average trade being worth of $6,926,668. The most recent stock trade was executed by John A Fry on 28 November 2022, trading 61,000 units of VTVT stock currently worth $50,630.
vtv therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. we have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and cancer.
vTv Therapeutics Inc executives and other stock owners filed with the SEC include: